Jpmorgan Chase & Co - Mar 31, 2025 SCHEDULE 13G Report for Cartesian Therapeutics, Inc. Common Stock, $0.0001 par value per share (RNAC)

Filing Manager: JPMORGAN CHASE & CO
Reporting Manager: JPMORGAN CHASE & CO.
Security: Cartesian Therapeutics, Inc. Common Stock, $0.0001 par value per share
Symbol: RNAC
Shares outstanding: 27.5M shares
Disclosed Ownership: 1.68M shares
Ownership: 6.1%
Form type: SCHEDULE 13G
Date filed: 4/25/2025, 02:57 PM
Date of event: Mar 31, 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
JPMORGAN CHASE & CO.	6.1%	1.68M	1.57M	0	Rachel Tsvaygoft	Vice President